Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Sunita Palmer

Pediatrics Webster, TX Medical Doctor

NPI 1316045610 CMS profile 105123

16 Professional Park, Webster, TX 77598

Open in the dashboard

General payments

$4,712

245 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$12,234 paid to institutions, not to them · program year 2022

Through program year 2025, Sunita Palmer of Webster, TX is reported in the CMS Open Payments database as having received $4,712 across 245 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $12,234 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 97th percentile of Pediatrics profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $532 20
2024 General $724 34
2023 General $588 27
2022 General $897 44
2021 General $727 41
2020 General $487 29
2019 General $757 50

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Sunita Palmer
  • Pediatrics median
  • Middle half of Pediatrics
  • National median

In program year 2025, general payments to Sunita Palmer were reported at $532. Among 22,296 Pediatrics profiles paid that year, the median was $97 and the middle half received between $37 and $210.

Show as a table
Year Sunita Palmer Pediatrics median Middle half National median
2019 $757 $86 $31–$183 $163
2020 $487 $49 $22–$110 $114
2021 $727 $68 $27–$158 $132
2022 $897 $77 $30–$173 $149
2023 $588 $88 $33–$190 $160
2024 $724 $94 $34–$206 $164
2025 $532 $97 $37–$210 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Tris Pharma Inc $986 61 payments
  2. Merck Sharp & Dohme Corporation $424 25 payments
  3. GlaxoSmithKline, LLC. $378 19 payments
  4. Neos Therapeutics, LP $374 24 payments
  5. Takeda Pharmaceuticals U.S.A., Inc. $315 12 payments
  6. Corium, Inc. $301 12 payments
  7. Cranial Technologies, Inc $293 20 payments
  8. Pfizer Inc. $208 9 payments
  9. Ironshore Pharmaceuticals Inc. $193 10 payments
  10. Sobi, Inc $173 6 payments
  11. Other $1,067 47 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $4,712 245 payments
Products named General payments · program years 2019–2025
  1. Quillivant $469 24 payments
  2. VYVANSE $344 14 payments
  3. BEXSERO $337 17 payments
  4. VAXELIS $328 18 payments
  5. COTEMPLA XR-ODT $320 20 payments
  6. ROTATEQ $315 19 payments
  7. Azstarys $301 12 payments
  8. Quillivant XR $299 25 payments
  9. Doc Band $293 20 payments
  10. GARDASIL 9 $214 13 payments
  11. Other $3,755 170 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

245 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Pediatrics in Texas

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record